Publications in collaboration with researchers from Post Graduate Institute of Medical Education and Research (28)

2023

  1. Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis

    Multiple sclerosis (Houndmills, Basingstoke, England), Vol. 29, Núm. 7, pp. 875-883

  2. Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY

    eClinicalMedicine, Vol. 65

  3. The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL

    American Journal of Hematology, Vol. 98, Núm. 12, pp. 1856-1868

  4. The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

    Brain : a journal of neurology, Vol. 146, Núm. 11, pp. 4633-4644

  5. The role of diagnostic tests in antifungal stewardship for treating invasive fungal infections: A plain language summary

    Future Microbiology, Vol. 18, Núm. 1, pp. 9-13

2022

  1. The Role of Diagnostics-Driven Antifungal Stewardship in the Management of Invasive Fungal Infections: A Systematic Literature Review

    Open Forum Infectious Diseases, Vol. 9, Núm. 7

  2. Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL

    Journal of Hematology and Oncology, Vol. 15, Núm. 1

2021

  1. COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

    Leukemia, Vol. 35, Núm. 12, pp. 3444-3454

  2. Mixinyeast: A multicenter study on mixed yeast infections

    Journal of Fungi, Vol. 7, Núm. 1, pp. 1-14

2020

  1. Needles in a haystack: Extremely rare invasive fungal infections reported in FungiScopeⓇ—Global Registry for Emerging Fungal Infections

    Journal of Infection, Vol. 81, Núm. 5, pp. 802-815

2018

  1. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

    Clinical Microbiology and Infection, Vol. 24, pp. e1-e38

2014

  1. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013

    Clinical Microbiology and Infection, Vol. 20, Núm. S3, pp. 5-26

  2. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: Diseases caused by black fungi

    Clinical Microbiology and Infection, Vol. 20, Núm. S3, pp. 47-75

  3. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others

    Clinical Microbiology and Infection, Vol. 20, Núm. S3, pp. 27-46

2013

  1. A research agenda on the management of intra-abdominal candidiasis: Results from a consensus of multinational experts

    Intensive Care Medicine, Vol. 39, Núm. 12, pp. 2092-2106

2012

  1. Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis

    Kidney International Supplements, Vol. 2, Núm. 2, pp. 139-274

2010

  1. Identifying predictors of central nervous system disease in solid organ transplant recipientswith cryptococcosis

    Transplantation, Vol. 89, Núm. 1, pp. 69-74

  2. Unrecognized pretransplant and donor-derived cryptococcal disease in organ transplant recipients

    Clinical Infectious Diseases, Vol. 51, Núm. 9, pp. 1062-1069

2009

  1. Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis

    Clinical Infectious Diseases, Vol. 49, Núm. 11, pp. 1721-1728

  2. Pulmonary zygomycosis in solid organ transplant recipients in the current era

    American Journal of Transplantation, Vol. 9, Núm. 9, pp. 2166-2171